Robert E. Sell, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 1,200 shares at $121.79 ($146K) on 2016-10-03, disclosed to the SEC on 2016-10-04.
Seasonal sale ($146k) by Group Chief Exec-Com, Med & Technology — this insider has traded ACN in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ACN | SELL | 2017-12-27 | $573K | — | Filing → |
| ACN | SELL | 2017-10-03 | $469K | — | Filing → |
| ACN | SELL | 2017-06-27 | $369K | — | Filing → |